A detailed history of Mercer Global Advisors Inc transactions in Repligen Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 2,679 shares of RGEN stock, worth $388,910. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,679
Previous 2,847 5.9%
Holding current value
$388,910
Previous $524,000 35.69%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$120.0 - $182.95 $20,160 - $30,735
-168 Reduced 5.9%
2,679 $337,000
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $133,720 - $163,192
783 Added 37.94%
2,847 $524,000
Q4 2023

Feb 14, 2024

SELL
$114.17 - $185.35 $7,192 - $11,677
-63 Reduced 2.96%
2,064 $371,000
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $212,749 - $270,589
-1,533 Reduced 41.89%
2,127 $338,000
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $43,879 - $57,158
317 Added 9.48%
3,660 $517,000
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $30,080 - $38,629
195 Added 6.19%
3,343 $562,000
Q4 2022

Feb 08, 2023

SELL
$162.42 - $220.56 $188,894 - $256,511
-1,163 Reduced 26.98%
3,148 $533,000
Q3 2022

Nov 15, 2022

BUY
$160.42 - $256.21 $62,082 - $99,153
387 Added 9.86%
4,311 $807,000
Q2 2022

Aug 10, 2022

SELL
$140.68 - $188.02 $122,391 - $163,577
-870 Reduced 18.15%
3,924 $637,000
Q1 2022

May 10, 2022

BUY
$161.19 - $257.96 $36,590 - $58,556
227 Added 4.97%
4,794 $902,000
Q4 2021

Feb 04, 2022

BUY
$247.59 - $304.47 $124,537 - $153,148
503 Added 12.38%
4,567 $1.21 Million
Q3 2021

Nov 10, 2021

SELL
$194.77 - $324.21 $14,997 - $24,964
-77 Reduced 1.86%
4,064 $1.17 Million
Q2 2021

Aug 10, 2021

SELL
$165.87 - $220.95 $35,496 - $47,283
-214 Reduced 4.91%
4,141 $827,000
Q1 2021

May 11, 2021

SELL
$180.37 - $226.26 $167,563 - $210,195
-929 Reduced 17.58%
4,355 $847,000
Q4 2020

Feb 12, 2021

BUY
$148.08 - $206.57 $268,469 - $374,511
1,813 Added 52.23%
5,284 $1.01 Million
Q3 2020

Dec 10, 2020

BUY
$122.51 - $158.27 $25,604 - $33,078
209 Added 6.41%
3,471 $512,000
Q2 2020

Aug 10, 2020

BUY
$94.33 - $140.48 $48,485 - $72,206
514 Added 18.7%
3,262 $403,000
Q1 2020

May 18, 2020

BUY
$84.96 - $109.14 $8,326 - $10,695
98 Added 3.7%
2,748 $265,000
Q4 2019

Feb 13, 2020

BUY
$73.84 - $93.08 $195,676 - $246,662
2,650 New
2,650 $245,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.06B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.